Term
Characteristics of Obstructive diseases |
|
Definition
s/sx are primarily related to expiration and ventilation is "worse on expiration"
increased WOB to remove air from the lungs
emptying lungs is slowed
"air trapping" |
|
|
Term
|
Definition
amount of air moved in and out with a normal breath; ~500mL |
|
|
Term
Minute Respiratory Volume |
|
Definition
amount of air moved in and out in one minute; ~6L |
|
|
Term
Inspiratory Reserve Volume |
|
Definition
maximum amount of air that can be inhaled over tidal volume; 2-3L |
|
|
Term
Expiratory reserve volume |
|
Definition
maximum amount of air that can be exhaled over tidal volume; ~1-1.5L |
|
|
Term
|
Definition
sum of the tidal volumes and the reserves |
|
|
Term
|
Definition
amount of air left in the lung after forced expiration; ~1-1/5L |
|
|
Term
Forced Vital Capacity (FVC) |
|
Definition
Pulmonary Function Test
records the maximum amount of air that can be exhaled as quickly as possible after maximum inhalation |
|
|
Term
|
Definition
maximum amount of air that can be exhaled in the 1st second of exhalation |
|
|
Term
|
Definition
compared as a ratio to diagnose pulmonary disease (primarily COPD) |
|
|
Term
|
Definition
chronic disorder that results in intermittent, reversible airway obstruction
- extremely common, incidence is rising
- bronchioles primarily affected
- inappropriate immune/inflamm response
- triggers
- genetic component
- permanent damage
|
|
|
Term
|
Definition
1) bronchoconstriction/bronchospasm
2) bronchiole edema (via vascular congestion)
2) excess mucus production
3) thickened airways & airway remodeling |
|
|
Term
Differences between normal lung and an asthmatic lung |
|
Definition
asthmatic lung:
smooth muscle constriction
mucus plug
hyperinflation of alveoli
degranulation of mast cell
mucus accumulation |
|
|
Term
|
Definition
decreased blood flow to the alveoli
alveoli over inflated
increased CO2
Capillary will shunt blood
right ventricle works harder |
|
|
Term
|
Definition
- increased IgE synthesis and airway inflammation, resulting in mast cell destruction and inflammatory mediator release
- mediator release causes bronchocontriction, increased capilly permeability, and mucus production
- generally presents in childhood or adolescense
- triggers: allergens such as food, pollen, dust, and medications
|
|
|
Term
|
Definition
- not an allergic reaction
- usually presents after age 35 years
- triggers: URI, air pollution, emotional stress, smoke, exercise, and cold exposure
|
|
|
Term
|
Definition
- usually occurs between 3am and 7am
- may be related to circadian rhythms... at night, cortisol and epi levels decrease, while histamine levels increase, leading to bronchoconstriction
|
|
|
Term
|
Definition
- usually occurs 10-15 minutes after activity
- symptoms can linger for an hour
- may be a compensaotry mechanism to warm and moisten the airways
- followed by a refractory period begins within 30 minutes and can last 90 minutes
|
|
|
Term
|
Definition
- caused by a reaction to substances at work
- symptoms develop over time, worsening with each exposure and improving when away from work
|
|
|
Term
|
Definition
- frequently caused by aspirin-- prevents the conversion of prostaglandins, which stimulate leukotriene release, a powerful bronchoconstrictor
- can be fatal
- reactions can be delayed up to 12 hours after drug ingestion
|
|
|
Term
Stage One of an Asthma Attack |
|
Definition
related to bronchospasms
it is usually signaled by coughing
peaking within 15-30 minutes
inflammatory mediators responsible include leukotrienes, histamines, and some interleukins |
|
|
Term
stage two of an asthma attack |
|
Definition
- peaks within 6 hours of symptom onset
- result of airway edema and increased mucus production
- the alveolar hyperinflation causes air trapping
- bronchospasm, smooth muscle contraction, inflammation, and mucus production combine to narrow the airways
|
|
|
Term
What are the ominous s/sx of near respiratory collapse? |
|
Definition
cyanosis
difficulty talking
stridor |
|
|
Term
Chronic Obstructive Pulmonary Disease (COPD) |
|
Definition
debilitating chronic disorders characterized by irreversible, progressive tissue degeneration and airway obstruction
two main conditions: chronic bronchitis and emphysema |
|
|
Term
|
Definition
smoking
pollution
chemical irritants
genetic mutation (2-5%) |
|
|
Term
|
Definition
|
|
Term
|
Definition
- characterized by inflammation of the bronchi, a productive cough, and excessive mucus production
- "Blue Bloaters"
|
|
|
Term
Complications of Chronic Bronchitis |
|
Definition
Frequent respiratory infections
respiratory failure |
|
|
Term
Assessment of Chronic Bronchitis |
|
Definition
Hypoventilation/hypercapnia
Hypoxemia/cyanosis
Polycythemia (Increased RBCs)
Clubbing of fingers
Dyspnea at rest
Wheezing
Edema and weight gain
malaise
chest pain
fever (chronic infection) |
|
|
Term
|
Definition
ALVEOLI
destruction of the alveolar walls leads to large permanently inflated alveoli (without the evidence of fibrosis)
airflow limitation is caused by a loss of elastic recoil and hyperinflation of the alveoli, leading to air trapping
"Pink Puffers" |
|
|
Term
|
Definition
1) genetic predisposition (enzyme deficient)
2) smoking |
|
|
Term
|
Definition
|
|
Term
|
Definition
Dyspnea upon exertion
diminished breath sounds
wheezing
chest tightness
tachypnea
hypoxia
hypercapnia
activity intolerance
anorexia
malaise |
|
|
Term
|
Definition
- same as chronic bronchitis (O2 therapy, bronchodilators, corticosteroids, antibiotics, postural drainage/chest physiotherapy, expectorants, increased hydration)
- pursed lip breathing
|
|
|
Term
COPD Presentation of "blue bloaters" |
|
Definition
- chronic bronchitis
- cyanotic/obese
- activity impairment
- not breathless, by "choice" = hypoventilation
- Worse ABG's
- CV problems
- Not fighters
|
|
|
Term
COPD presentation of "Pink Puffers" |
|
Definition
Emphysema
red/puffer = hyperventilation (noticed more in the clinical setting)
thin: wasting, related to work of breathing
pursed lip breathing
ABGs less abnormal |
|
|